SHORT REPORT
Survival probability in ataxia telangiectasia
1 Department of Neurology, The Johns Hopkins Hospital, Baltimore, Maryland, USA
2 Department of Pediatrics, The Johns Hopkins Hospital
3 Ataxia Telangiectasia Childrens Project, Deerfield Beach, Florida, USA
Correspondence to:
Correspondence to:
Dr Thomas O Crawford
Pediatric Neurology, Johns Hopkins Hospital, Jefferson 123, 600 N Wolfe Street, Baltimore, MD 21287, USA; tcrawfo{at}jhmi.edu
Ataxia telangiectasia is a rare, multiorgan neurodegenerative disorder with enhanced vulnerability to cancer and infection. Median survival in two large cohorts of patients with this disease, one prospective and one retrospective, is 25 and 19 years, with a wide range. Life expectancy does not correlate well with severity of neurological impairment.
Abbreviations: ATCC, Ataxia Telangiectasia Clinical Center at Johns Hopkins Hospital; ATCP, Ataxia Telangiectasia Childrens Project
Keywords: survival analysis; cancer; ataxia telangiectasia
Relevant Article
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Arch. Dis. Child. 2006 91: e1.
This article has been cited by other articles:
-
Erichsen, A. K., Koht, J., Stray-Pedersen, A., Abdelnoor, M., Tallaksen, C. M. E.
(2009). Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain
132: 1577-1588
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



